http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1128094-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f564e8ae29bf6aa0572ce3eec2e20ba2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C11-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C407-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C29-132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C5-3332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D301-19
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C1-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C31-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C239-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D301-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C407-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C5-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C11-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C1-00
filingDate 1966-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4df0f684352124b42a8fd00b9c97680b
publicationDate 1968-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1128094-A
titleOfInvention Improvements in or relating to the production of isoprene
abstract 1,128,094. Conversion of isopentane to isoprene. HALCON INTERNATIONAL Inc. 20 May, 1966 [25 May, 1965], No. 22660/66. Heading C2C. [Also in Division C5] In a process scheme for yielding isoprene starting from isopentane hydroperoxide (see Division C5), the first stage involves reacting the hydroperoxide with a second reactant (e.g. an olefin, amine or unsaturated aldehyde) under conditions such that the second reactant is oxidized while the hydroperoxide is converted to t-amyl alcohol. Numerous second reactants are specified, as also are suitable reaction conditions and catalysts for each type of reactant, the following reactions occurring in specific examples (one product being t-amyl alcohol in each case):- (1) Propylene -# propylene oxide, using molybdenum naphthenate as catalyst. Byproduct methyl isopropyl ketone is hydrogenated over copper chromite catalyst to give further t-amyl alcohol. (2) Cyclohexylamine --> cyclohexanone oxime, using tetra-n-butyl titanate as catalyst. (3) Methacrolein --> methacrylic acid, using chromic oxide as catalyst. The following reactions, occurring at different stages of the process scheme, are also exemplifled:- (a) Isopentane --> isopentane hydroperoxide, using O 2 in the presence of butyl hydroperoxide. (b) Isopentene --> isopentene epoxides, using air in the presence of cobalt naphthenate.
priorityDate 1965-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407932856
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454703594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448899939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11770311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421183272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457765275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407272724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416604284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425064323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407043279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414262147
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14048876
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID162243947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449631196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11251

Total number of triples: 64.